During a live event, Shuo Ma, MD, PhD, discussed the outcomes of the BRUIN trial of pirtobrutinib in BTK inhibitor–pretreated ...

AstraZeneca’s biologics division MedImmune ... Viela Bio will be based in the same town as MedImmune, Gaithersburg in Maryland, suggesting its focus is on maintaining close relations with ...

HHS Secretary Robert F. Kennedy Jr. and biopharmas will negotiate drug prices individually. Kennedy could "propose a rulemaking plan to impose MFN pricing" if no “significant” progress has been made.

As for safety, Eli Lilly said this trial "was not powered to compare the safety and tolerability of Zepbound and the safety ...

The price cuts would see that U.S. consumers pay the same amount as the nation that pays the lowest price for that drug.

The CAR-T industry is booming, with a significant surge in funding driven by successful therapies hitting the market. Over 170 companies are actively developing CAR-T products, with 1,944 therapies in ...

AstraZeneca is backing up its considerable investment in antibody-drug conjugates (ADCs) for cancer with the construction of a $1.5 billion new facility in Singapore to manufacture them.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.